Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function.

Area of Science:

• Cellular Biology
• Molecular Medicine
• Diabetes Research

Background:

• Hyperglycemia and hypoxia are implicated in diabetes complications.
• Cellular adaptive responses to hypoxia are crucial for tissue function.
• Hypoxia-inducible factor-1 (HIF-1) is a key regulator of cellular adaptation to low oxygen.

Purpose of the Study:

• To investigate how hyperglycemia affects the function of HIF-1.
• To elucidate the mechanisms by which diabetes may impair cellular responses to hypoxia.
• To assess the in vivo relevance of hyperglycemia's effect on HIF-1 in diabetic conditions.

Main Methods:

• Primary dermal fibroblasts and endothelial cells were used to study HIF-1 function.
• Experiments involved proteasomal and prolyl hydroxylases inhibitors.
• Hypoxia-inducible reporter gene assays assessed HIF-1 transcriptional activity.
• In vivo studies compared HIF-1 levels in diabetic wounds and chronic venous ulcers.

Main Results:

• Hyperglycemia inhibits the stabilization of HIF-1alpha protein under hypoxia.
• This inhibition is dose-dependent and reduces HIF-1's transcriptional activation.
• Mannitol mimicked hyperglycemia's effect, suggesting hyperosmolarity plays a role.
• Significantly lower HIF-1alpha protein levels were observed in diabetic wounds compared to venous ulcers.

Conclusions:

• Hyperglycemia impairs the protection of HIF-1alpha against proteasomal degradation.
• Diabetes interferes with cellular adaptive responses to hypoxia via HIF-1 dysfunction.
• This study reveals a molecular mechanism contributing to diabetes-related complications.